Live Breaking News & Updates on Nephrology|Page 2

Stay updated with breaking news from Nephrology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Immune cells play a bigger role in high blood pressure than previously thought, opening doors for new treatments

A review in Nature Reviews Nephrology presents the association between immune cells and the development of hypertension, suggesting potential new therapeutic targets to mitigate the disease by managing inflammation. ....

United States , Meletios Verras , Nature Reviews Nephrology , Blood Pressure , High Blood Pressure ,

Max Super Speciality Hospital: Doctors perform combined liver and kidney transplant on critically ill patient from Uzbekistan, ET HealthWorld

Max Super Speciality Hospital: The patient presented with the history of recurrent ascites (water in tummy), needing multiple admission for draining the water. When he visited Max Hospital, Vaishali, upon evaluation it was found that he had a liver cirrhosis as well as a non-functioning kidney, the hospital said in a statement. ....

New Delhi , Anant Kumar , Akhrorjon Khaydarov , Subhash Gupta , Neeru Aggarwal , Rajesh Dey , Biliary Sciences , Centre For Liver , Max Hospital , Principal Director , Kidney Transplant , Max Super Speciality Hospital , Associate Director , Centre For Liver And Biliary Sciences , Biliary Sciences , Health News , Dvanced Kidney Failure , Unwavering Focus , Idney Transplant Departments , Pecialised Transplant Operating Theatre , Kidney Transplant ,

Pazopanib does not improve disease-free survival post-metastasectomy for renal cell carcinoma patients

1. Pazopanib did not improve disease-free survival in post-metastasectomy renal cell carcinoma patients 2. There was a concerning trend favouring placebo when assessing overall survival, suggesting a negative impact of pazopanib. Evidence Rating Level: 1(Excellent) Study Rundown: The E2810 trial was a randomized, double-blind phase III trial assessing the impact of pazopanib on patients with ....

Rating Level , Chronic Disease ,